Journal of Shandong University (Health Sciences) ›› 2018, Vol. 56 ›› Issue (4): 51-57.doi: 10.6040/j.issn.1671-7554.0.2017.850
WANG Bo, XUE Jiang, LIU Aihong, ZHAI Ruirui, WANG Yibiao
CLC Number:
[1] Desai A, Desouza SA. Treatment of pulmonary hypertension with left heart disease: a concise review[J]. Vasc Health Risk Manag, 2017, 13: 415-420. [2] Pereira SL, Kummerle AE, Fraga CA, et al. A novel Ca2+ channel antagonist reverses cardiac hypertrophy and pulmonary arteriolar remodeling in experimental pulmonary hypertension[J]. Eur J Pharmacol, 2013, 702(1-3): 316-322. [3] Alencar AK, Pereira SL, Montagnoli TL, et al. Beneficial effects of a novel agonist of the adenosine A2A receptor on monocrotaline-induced pulmonary hypertension in rats[J]. Br J Pharmacol, 2013, 169(5): 953-962. [4] 余莉,范志宇,谢亮,等.雷帕霉素逆转大鼠肺动脉高压的作用机制研究[J].中国当代儿科杂志,2015, 17(7):731-735. YU Li, FAN Zhiyu, XIE Liang, et al. Mechanisms for reversal of pulmonary hypertension by rapamycin in rats[J]. Chin J Contemp Pediatr, 2015, 17(7):731-735. [5] Wang AP, Li XH, Yang YM, et al. A critical role of the mTOR/eIF2α pathway in hypoxia-induced pulmonary hypertension[J]. PLoS One, 2015, 10(6): e0130806. doi: 10.1371/journal.pone.0130806. [6] Zhu L, Yang T, Li L, et al. TSC1 controls macrophage polarization to prevent inflammatory disease[J]. Nat Commun, 2014, 5: 4696. [7] Kishimoto Y, Kato T, Ito M, et al. Hydrogen ameliorates pulmonary hypertension in rats by anti-inflammatory and antioxidant effects[J]. J Thorac Cardiovasc Surg, 2015, 150(3): 645-654. [8] Vaillancourt M, Ruffenach G, Meloche J, et al. Adaptation and remodelling of the pulmonary circulation in pulmonary hypertension[J]. Can J Cardiol, 2015, 31(4): 407-415. [9] Kiss T, Kovacs K, Komocsi A, et al. Novel mechanisms of sildenafil in pulmonary hypertension involving cytokines/chemokines, MAP kinases and Akt[J]. PLoS One, 2014, 9(8): e104890. doi: 10.1371/journal.pone.0104890. [10] Vergadi E, Chang MS, Lee C, et al. Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension[J]. Circulation, 2011, 123(18): 1986-1995. [11] Chen T, Yang C, Li M, et al. Alveolar hypoxia-induced pulmonary inflammation: from local initiation to secondary promotion by activated systemic inflammation[J]. J Vasc Res, 2016, 53(5-6): 317-329. [12] Yeager ME, Reddy MB, Nguyen CM, et al. Activation of the unfolded protein response is associated with pulmonary hypertension[J]. Pulm Circ, 2012, 2(2): 229-240. [13] Tian W, Jiang X, Tamosiuniene R, et al. Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension[J]. Sci Transl Med, 2013, 5(200): 200ra117. [14] Martinez FO, Sica A, Mantovani A, et al. Macrophage activation and polarization[J]. Front Biosci, 2008, 13: 453-461. [15] 刘斌,王献民,魏丽,等. 4种肺动脉高压动物模型肺血管重构模式的差异研究[J].中国病理生理杂志, 2008, 24(2): 289-293. LIU Bin, WANG Xianmin, WEI Li, et al. Differentiation of pulmonary vascular remodeling pattern in 4 models of pulmonary hypertension[J]. Chinese Journal of Pathophysiology, 2008, 24(2): 289-293. [16] Vats D, Mukundan L, Odegaard JI, et al. Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation[J]. Cell metabolism, 2006, 4(1): 13-24. [17] Price LC, Wort SJ, Perros F, et al. Inflammation in pulmonary arterial hypertension[J]. Chest, 2012, 141(1): 210-221. [18] Hansson GK. Atherosclerosis-an immune disease: the Anitschkov Lecture 2007[J]. Atherosclerosis, 2009, 202(1): 2-10. [19] Perros F, Dorfmüller P, Montani D, et al. Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension[J]. Am J Respir Crit Care Med, 2012, 185(3): 311-321. [20] Sutendra G, Dromparis P, Bonnet S, et al. Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertension[J]. J Mol Med(Berl), 2011, 89(8): 771-783. [21] 郑亚国.肺动脉高压免疫炎症机制研究进展[J].中国循环杂志, 2013, 28(6): 469-471. [22] Antunes MA, Abreu SC, Cruz FF, et al. Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema[J]. Respir Res, 2014, 15: 118. [23] Vergadi E, Chang MS, Lee C, et al. Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension[J]. Circulation, 2011, 123(18): 1986-1995. [24] Ogawa A, Nakamura K, Matsubara H, et al. Prednisolone inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension[J]. Circulation, 2005, 112(12): 1806-1812. [25] Price LC, Montani D, Tcherakian C, et al. Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats[J]. Eur Respir J, 2011, 37(4): 813-822. [26] Ma X, Yao J, Yue Y, et al. Rapamycin reduced pulmonary vascular remodelling by inhibiting cell proliferation via Akt/mTOR signalling pathway down-regulation in the carotid artery-jugular vein shunt pulmonary hypertension rat model[J]. Interact Cardiovasc Thorac Surg, 2017, 25(2): 206-211. [27] Segura-Ibarra V, Amione-Guerra J, Cruz-Solbes AS, et al. Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension[J]. Int J Pharm, 2017, 524(1-2): 257-267. [28] Aghamohammadzadeh R, Zhang YY, Stephens TE, et al. Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension[J]. FASEB J, 2016, 30(7): 2511-2527. |
[1] | XIANG Yujiao, LIU Qiang, LIU Lu, SHI Yan. Mechanism of abnormal immune response of dendritic cells in immune thrombocytopenia [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 89-97. |
[2] | ZHANG Ludan, DING Xiaoling, CUI Shuyue, CHENG Chen, WEI Fulan, DING Gang. Periodontal ligament stem cells regulate the functions of macrophages in vitro [J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 35-40. |
[3] | JIANG Yong, SONG Jiangang, ZHU Daxia, LIU Lijian. Effects of naringenin on acute lung injury induced by sepsis via regulating the activation of NLRP3 inflammasome in macrophages [J]. Journal of Shandong University (Health Sciences), 2021, 59(1): 14-21. |
[4] | FU Jieqi, ZHANG Man, ZHANG Xiaolu, LI Hui, CHEN Hong. Molecular mechanism of Toll-like receptor 4 in the aggravation of blood lipid accumulation by inhibiting the peroxisome proliferator-activate receptor γ [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 24-31. |
[5] | ZHANG Xiaolu, WANG Lili, CHEN Kaiming, LOU Xianzhi, ZHANG Man. Mechanism of histone deacetylase SIRT1 inhibiting macrophages apoptosis via TLR4 signaling pathway [J]. Journal of Shandong University (Health Sciences), 2020, 58(12): 8-14. |
[6] | ZHANG Luan, CHEN Ou, LUAN Yun, ZHU Xiaobo, CHEN Yuan, WANG Yibiao. Effects of gemigliptin on the therapeutic effect and inflammatory factors of monocrotaline-induced pulmonary arterial hypertension in rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 19-22. |
[7] | CHEN Yikun, WANG Ketao, WANG Huayang, SHAO Qianqian, TAN Wanye, SONG Xiaobin, QU Xun, WEI Fengcai. Regulatory role of KIF4A in the expression of angiogenesis- associated factors of macrophages [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 39-43. |
[8] | ZONG Zhaoyun, LI Xia, HAN Zhenlong, WANG Xianteng, GUO Chun, ZHANG Lining, SHI Yongyu. Effect of tumor associated macrophages on the expression of c-Met in hepatocellular carcinoma cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 14-18. |
[9] | LIU Huimin, LIU Deng, LI Xiaoyu, ZOU Shufeng, JIANG Limin, LI Yuhuan. Effect of Lobelia alkaloids on endothelin-1 signal pathway in a rat model of pulmonary arterial hypertension [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(8): 1-4. |
[10] | TANG Mengmeng, JIN Nüwa, LIU Chuanzhen, LIU Kai, CAO Guangqing, WANG He, PANG Xinyan, WU Shuming. Effects of ethyl pyruvate in the treatment of hyperkinetic pulmonary hypertension [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(5): 75-80. |
[11] | FENG Qing, TAN Xiaodong. L161982 influences macrophage subtypes in rats with experimental autoimmune neuritis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(10): 21-25. |
[12] | HAN Wenjie1, YU Suguo1, CUI Xiangyu2. Effects of N-acetylcysteine on GLP-1 and IL-6 in high-fat-diet rats with insulin resistance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(6): 12-16. |
[13] | QIU Huihui1, YE Liping1, WEN Youfeng2, LI Dan1, SONG Jia1. Effects of IL-6 on the expressions of bcl-2,cyclinD1 and VEGF in ovarian cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(6): 17-21. |
[14] | WANG Hao1, LI Xia2, WANG Chao3, LI Guosheng1, GUO Chun1, ZHU Faliang1, ZHANG Lining1, SHI Yongyu1. Role of tumor-associated macrophages in epithelial-mesenchymal transition of human hepatocellular carcinoma cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(4): 8-12. |
[15] | DONG Zhaojing, SHANG Qianwen, GUO Chun, ZHANG Lining, WANG Qun . Effect of PDCD4 siRNA on the lipid accumulation in macrophages#br# [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(4): 18-21. |
|